DID Press: Russian health officials announced the successful completion of preclinical trials for a new cancer vaccine, which can potentially save patients’ lives.
According to Russian media reports, the vaccine has been shown in preclinical studies to shrink tumors, slow their growth, and extend patients’ lifespans.
The Russian Federal Medical and Biological Agency has submitted the necessary documentation to the Ministry of Health for official approval.
The vaccine will initially be used to treat colorectal cancer and is planned to be further developed for glioblastoma and melanoma.
Health authorities described the vaccine as “a major step forward in personalized cancer treatment.”